Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases

E Beurel, SF Grieco, RS Jope - Pharmacology & therapeutics, 2015 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK3) may be the busiest kinase in most cells, with
over 100 known substrates to deal with. How does GSK3 maintain control to selectively …

Recent applications of the multicomponent synthesis for bioactive pyrazole derivatives

D Becerra, R Abonia, JC Castillo - Molecules, 2022 - mdpi.com
Pyrazole and its derivatives are considered a privileged N-heterocycle with immense
therapeutic potential. Over the last few decades, the pot, atom, and step economy (PASE) …

Glycogen synthase kinase-3 inhibitors: preclinical and clinical focus on CNS-A decade onward

SM Arciniegas Ruiz, H Eldar-Finkelman - Frontiers in molecular …, 2022 - frontiersin.org
The protein kinase, GSK-3, participates in diverse biological processes and is now
recognized a promising drug discovery target in treating multiple pathological conditions …

Multifaceted roles of GSK‐3 in cancer and autophagy‐related diseases

R Mancinelli, G Carpino, S Petrungaro… - Oxidative medicine …, 2017 - Wiley Online Library
GSK‐3 is a ubiquitously expressed serine/threonine kinase existing as GSK‐3α and GSK‐
3β isoforms, both active under basal conditions and inactivated upon phosphorylation by …

Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer's disease

M Maqbool, M Mobashir, N Hoda - European journal of medicinal chemistry, 2016 - Elsevier
Neurodegenerative diseases are among the most challenging diseases with poorly known
mechanism of cause and paucity of complete cure. Out of all the neurodegenerative …

[HTML][HTML] Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer

JA McCubrey, D Rakus, A Gizak, LS Steelman… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase that participates
in an array of critical cellular processes. GSK-3 was first characterized as an enzyme that …

Mechanisms and therapeutic implications of GSK-3 in treating neurodegeneration

I Rippin, H Eldar-Finkelman - Cells, 2021 - mdpi.com
Neurodegenerative disorders are spreading worldwide and are one of the greatest threats to
public health. There is currently no adequate therapy for these disorders, and therefore there …

Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions

AP Saraswati, SMA Hussaini, NH Krishna… - European journal of …, 2018 - Elsevier
Abstract Glycogen Synthase Kinase-3 (GSK-3) is a serine/threonine kinase which is
ubiquitously expressed and is regarded as a regulator for various cellular events and …

Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical …

S Schenone, M Radi, F Musumeci, C Brullo… - Chemical …, 2014 - ACS Publications
1. INTRODUCTION Nitrogen-containing heterocycles are widely distributed in nature and
essential for life, playing a vital role in the metabolism of all living cells. Among the many …

Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1, 2, 4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as …

M Wang, T Liu, S Chen, M Wu, J Han, Z Li - European Journal of Medicinal …, 2021 - Elsevier
Pleiotropic intervention has prominent advantages for complex pathomechanisms, such as
Alzheimer's disease (AD). In this study, a series of novel 3-(4-pyridyl)-5-(4-sulfamido-phenyl) …